Ian Wakefield

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study

Anthony Shock, Linda C. Burkly, Ian Wakefield et al. · Arthritis Research & Therapy · 2015 · 107 citations · Full text

Life Sciences, Hematology, Immunology +13

Safety pharmacology – a progressive approach

William S. Redfern, Ian Wakefield, Helen Prior et al. · Fundamental and Clinical Pharmacology · 2002 · 97 citations

Pharmacy, Pharmacology, Clinical Pharmacology +16

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke

Grant Mair, Rüdiger von Kummer, Zoë Morris et al. · Neurology · 2015 · 41 citations · Full text

Medicine, Neurology, Radiology +17

Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, <i>S</i>‐methyl‐<scp>L</scp>‐thiocitrulline and <scp>L</scp>‐NAME, in conscious rats

Ian Wakefield, J E March, Philip A. Kemp et al. · British Journal of Pharmacology · 2003 · 36 citations · Full text

Medicine, Pharmacology, Cardiovascular Pharmacotherapy +11

The Use of Surrogate Antibodies to Evaluate the Developmental and Reproductive Toxicity Potential of an Anti-TNFα PEGylated Fab′ Monoclonal Antibody

Ian Wakefield, Sue Stephens, Roly Foulkes et al. · Toxicological Sciences · 2011 · 34 citations · Full text

Pharmacy, Immunology, Toxicology +17